Delisting risk
Akari Therapeutics (ADR) (AKTX)
Develops preclinical oncology antibody-drug conjugates based on its PH1 payload platform.
$10.02
Pre-market−0.13 (−1.28%)
At close$10.15(−2.12%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Nov '24Apr '25May '25Aug '25Nov '25Apr '26May '26Aug '26
Reported−$9.60−$0.17−$0.14−$0.06−$4.00−$2.99−$9.74−$272.00
Estimate−$0.60−$1.00—−$0.09−$1.60−$1.80−$1.33−$1.04
Surprise−1,500.0%+83.0%—+33.3%−150.0%−66.1%−632.3%−26,053.8%
RevenueReportedEstimate
Nov '24Apr '25May '25Aug '25Nov '25Apr '26May '26Aug '26
Reported————————
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$1.04 | −$272.00 | −26,053.8% |
| May 2026 | −$1.33 | −$9.74 | −632.3% |
| Apr 2026 | −$1.80 | −$2.99 | −66.1% |
| Nov 2025 | −$1.60 | −$4.00 | −150.0% |
The latest year is open to everyone — the 42 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Oct 2023 | |||
| Sep 2023 | |||
| Jul 2023 | |||
| Mar 2023 | |||
| Mar 2023 | |||
| Mar 2023 | |||
| Sep 2022 | |||
| Jul 2022 | |||
| May 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Apr 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Apr 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Oct 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| May 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | −$1.04 | −$272.00 | −26,053.8% | — | — | — | −2.5% |
| May 19, 2026 | −$1.33 | −$9.74 | −632.3% | — | — | — | −8.3% |
| Apr 7, 2026 | −$1.80 | −$2.99 | −66.1% | — | — | — | +2.1% |
| Nov 13, 2025 | −$1.60 | −$4.00 | −150.0% | — | — | — | +1.7% |
The latest year is open to everyone — the 42 quarters behind it read with an account. Sign in | |||||||
| Aug 13, 2025 | |||||||
| May 14, 2025 | |||||||
| Apr 14, 2025 | |||||||
| Nov 19, 2024 | |||||||
| Aug 19, 2024 | |||||||
| May 15, 2024 | |||||||
| Mar 29, 2024 | |||||||
| Oct 3, 2023 | |||||||
| Sep 26, 2023 | |||||||
| Jul 19, 2023 | |||||||
| Mar 27, 2023 | |||||||
| Mar 13, 2023 | |||||||
| Mar 9, 2023 | |||||||
| Sep 27, 2022 | |||||||
| Jul 20, 2022 | |||||||
| May 16, 2022 | |||||||
| Dec 3, 2021 | |||||||
| Sep 22, 2021 | |||||||
| Jun 29, 2021 | |||||||
| Apr 20, 2021 | |||||||
| Dec 11, 2020 | |||||||
| Sep 1, 2020 | |||||||
| May 29, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Nov 4, 2019 | |||||||
| Aug 29, 2019 | |||||||
| Apr 23, 2019 | |||||||
| Nov 15, 2018 | |||||||
| Aug 17, 2018 | |||||||
| Mar 21, 2018 | |||||||
| Nov 13, 2017 | |||||||
| Oct 18, 2017 | |||||||
| Aug 10, 2017 | |||||||
| May 15, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Aug 11, 2016 | |||||||
| May 12, 2016 | |||||||
| Mar 23, 2016 | |||||||
| Nov 23, 2015 | |||||||
| Aug 12, 2015 | |||||||
| May 12, 2015 | |||||||